The shares of Gray Television, Inc. (NYSE:GTN) started off the last trading session with the price of $13.65 while closing the day with the price of $13.75. The shares of Gray Television, Inc. (NYSE:GTN) Rise 0.73% with the Gain of 0.1 points.
The shares of Gray Television, Inc. (NYSE:GTN) traded with the day volume of 571902 shares whereas its average trading volume is 1.07 Million.
While analyzing the past performance of the stock we can see that the shares of Gray Television, Inc. (NYSE:GTN) Gain 0.36% in the last week while Falling -8.94% in the last month. Past quarter performance shows the red light with -9.24%. The semi-annual and annual performance shows 0.36% and -2.48% respectively.
Some critical values of the shares of Gray Television, Inc. (NYSE:GTN) to be discussed here are: the beta which shows the value at 2.53 while Average True Range of Gray Television, Inc. (NYSE:GTN) demonstrate the value at 0.57. The weekly and monthly volatility of the shares of Gray Television, Inc. (NYSE:GTN) are indicated at 2.55% and 3.81%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 37.83.
While studying the financial position of the shares of Gray Television, Inc. (NYSE:GTN), we can see that the Market capitalization of the company is at 1.2 Billion. The shares outstanding for the company is 87.08 Million and the shares float stands at 79.24 Million. The income of the company stand at 116 Million while the sales stand at 882.7 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.58, Price to Earnings or P/E is at 8.7, Price to Sales P/S show the value of 1.36, the Return on Asset ROA stood at 0.087 and the Return on Equity ROE depicted at 0.394 while Return on Investment ROI is at 0.075.
Clovis Oncology, Inc. (NASDAQ:CLVS)
Clovis Oncology, Inc. (NASDAQ:CLVS) started its previous trading session at $62.53 and closed at $62.34 showing a Rise of 0.35 Percent.
The Company traded with an average Volume of 1.31 Million whereas, its Day Volume stood at 557842.
Looking at the performance of the stock, Clovis Oncology, Inc. (NASDAQ:CLVS) Gain 4.63% in the last week in its shares price and 24.38% in the last month. Quarterly performance shows a green of 4.79 Percent while Semi-Annual and Annual performances shows a -7.19 and -0.1 percent respectively.
Beta for Clovis Oncology, Inc. (NASDAQ:CLVS) stands at 0.86 while the ATR (average true range) is at 2.89. The Stock’s Weekly and Monthly Volatility is 3.80% and 5.35% respectively showing a RSI value of 60.29.
While studying the financial position of the shares of Clovis Oncology, Inc. (NASDAQ:CLVS), we can see that the Market capitalization of the company is at 3.03 Billion. The shares outstanding for the company is 48.65 Million and the shares float stands at 47.39 Million.
The Company generated an income of -184200000 and the sales of 55.5 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-4.24 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 54.65 respectively.
The Return on Assets stands at -0.473, ROE shows a value of -1.169 and ROI for Clovis Oncology, Inc. (NASDAQ:CLVS) is -0.273 as of Trailing Twelve Months period.
